Nexalin Technology, Inc. (NXL): Total Assets

Annual figures by period end, from SEC filings.

$4.64M
As of 2025-12-31
$3.00M
As of 2026-06-30
-14.6%
3-year compound annual growth
$7.43M2021-12-31: $753.7K2022-12-31: $7.43M2023-12-31: $3.63M2024-12-31: $4.22M2025-12-31: $4.64M$4.64M
2021-12-31 Total Assets (USD) 2025-12-31
Period endedTotal AssetsChange YoYSource filing
2025-12-31$4.64M+9.8%2026-03-25, Balance as of period end
2024-12-31$4.22M+16.3%2026-03-25, Balance as of period end
2023-12-31$3.63M-51.1%2025-09-23, Balance as of period end
2022-12-31$7.43M+886.1%2024-03-27, Balance as of period end
2021-12-31$753.7Kn/a2023-03-27, Balance as of period end

Total Assets at similar companies

Companies with the same SEC industry code (Electromedical & Electrotherapeutic Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedTotal AssetsChange YoY
Nexalin Technology, Inc. (NXL)2025-12-31$4.64M+9.8%
Positron Corp (POSC)2025-12-31$4.00M+122.1%
iTonic Holdings Ltd (ITOC)2025-12-31$9.10M+35.3%
Guided Therapeutics Inc (GTHP)2025-12-31$1.32M-3.9%
Hongchang International Co., Ltd (HCIL)2024-12-31$57.45M+14.4%
ADM Tronics Unlimited, Inc. (ADMT)2026-03-31$1.83M-14.2%
Neuraxis, Inc (NRXS)2025-12-31$6.40M+34.6%
Yubo International Biotech Ltd (YBGJ)2025-12-31$847.1K-44.8%
Nuwellis, Inc. (NUWE)2025-12-31$6.12M-38.0%

Compare NXL, POSC, ITOC, GTHP side by side · Screen every company in Electromedical & Electrotherapeutic Apparatus ↗